ClinicalTrials.Veeva

Menu

The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

HIV Infections

Study type

Observational

Funder types

NIH

Identifiers

NCT01034800
999906300
06-DA-N300

Details and patient eligibility

About

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....

Full description

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Data analysis protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems